Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 118

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 118
---
 results, bill payers or patients, process claims and appeals, provide customer assistance, conduct research and development activities, collect, process and prepare company financial information, provide information about our tests and other patient and physician education and outreach efforts through our website, and manage the administrative aspects of our business. Any such access, disruption, disclosure, or other loss of information could result in an adverse impact on our or our customers’ business, legal claims or proceedings, liability under laws that protect the privacy of personal information, and damage to our reputation, all of which would have an adverse impact on our business, financial condition, results of operations and growth prospects. In addition to data security risks, we face privacy risks. Should we actually violate, or be perceived to have violated, any privacy commitments we make to patients or consumers, we could be subject to a complaint from an affected individual or interested privacy regulator, such as the Federal Trade Commission, a state Attorney General, an EU Member State Data Protection Authority, or a data protection authority in another international jurisdiction. This risk is heightened given the sensitivity of the data we collect. A violation, or perceived violation, of such privacy commitments would have an adverse impact on our business, financial condition, results of operations and growth prospects. We depend on third -party manufacturers and suppliers and rely on commercial courier delivery services. If any of these suppliers or services are delayed or interrupted, our business could be materially harmed. The complex nature of our products requires customized, precision -manufacturedsub -assemblies, components, and materials that currently are available from a limited number of sources, and, in the case of some sub -assemblies, components, and materials, from only a single source. If deliveries from Illumina and/or CIBIC, our suppliers on which we depend exclusively for certain sub -assemblies, components and materials, are delayed or interrupted for any reason, or if we are otherwise unable to secure a sufficient supply, we may not be able to obtain these sub -assemblies, components, or materials on a timely basis or in sufficient quantities or at satisfactory qualities. We may need to enter into contractual relationships with manufacturers for commercial -scaleproduction of some of our products, in whole or in part, or develop these capabilities internally, and there can be no assurance that we will be able to do this on a timely basis, in sufficient quantities, or on commercially reasonable terms. In addition, the lead time needed to establish a relationship with a new supplier can be lengthy, and we may experience delays and increased